Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Problems of reproductive function in survivors of childhood- and adolescent and young adult-onset cancer revealed in a part of a national survey of Japan.

Furui T, Takai Y, Kimura F, Kitajima M, Nakatsuka M, Morishige KI, Higuchi A, Shimizu C, Ozawa M, Ohara A, Tatara R, Nakamura T, Horibe K, Suzuki N.

Reprod Med Biol. 2018 Nov 20;18(1):105-110. doi: 10.1002/rmb2.12255. eCollection 2019 Jan.

PMID:
30655728
2.

Fertility preservation in adolescent and young adult cancer patients: From a part of a national survey on oncofertility in Japan.

Furui T, Takai Y, Kimura F, Kitajima M, Nakatsuka M, Morishige KI, Higuchi A, Shimizu C, Ozawa M, Ohara A, Tatara R, Nakamura T, Horibe K, Suzuki N.

Reprod Med Biol. 2018 Nov 20;18(1):97-104. doi: 10.1002/rmb2.12256. eCollection 2019 Jan.

PMID:
30655727
3.

Kinetic Study of the Quenching Reaction of Singlet Oxygen by Eight Vegetable Oils in Solution.

Mukai K, Ohara A, Ito J, Hirata M, Kobayashi E, Nakagawa K, Nagaoka SI.

J Oleo Sci. 2019 Jan 1;68(1):21-31. doi: 10.5650/jos.ess18179. Epub 2018 Dec 12.

4.

PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer.

Ohara AM, Naoi Y, Shimazu K, Kagara N, Shimoda M, Tanei T, Miyake T, Kim SJ, Noguchi S.

Breast Cancer Res Treat. 2018 Oct 25. doi: 10.1007/s10549-018-5020-7. [Epub ahead of print]

PMID:
30361874
5.

Clinical and Immunological Characterization of ICF Syndrome in Japan.

Kamae C, Imai K, Kato T, Okano T, Honma K, Nakagawa N, Yeh TW, Noguchi E, Ohara A, Shigemura T, Takahashi H, Takakura S, Hayashi M, Honma A, Watanabe S, Shigemori T, Ohara O, Sasaki H, Kubota T, Morio T, Kanegane H, Nonoyama S.

J Clin Immunol. 2018 Nov;38(8):927-937. doi: 10.1007/s10875-018-0559-y. Epub 2018 Oct 23.

PMID:
30353301
6.

Correction to: Current situation of cancer among adolescents and young adults in Japan.

Ohara A, Furui T, Shimizu C, Ozono S, Yamamoto K, Kawai A, Tatara R, Higuchi A, Horibe K.

Int J Clin Oncol. 2018 Dec;23(6):1212-1216. doi: 10.1007/s10147-018-1342-z.

PMID:
30324312
7.

Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion.

Ohki K, Kiyokawa N, Saito Y, Hirabayashi S, Nakabayashi K, Ichikawa H, Momozawa Y, Okamura K, Yoshimi A, Ogata-Kawata H, Sakamoto H, Kato M, Fukushima K, Hasegawa D, Fukushima H, Imai M, Kajiwara R, Koike T, Komori I, Matsui A, Mori M, Moriwaki K, Noguchi Y, Park MJ, Ueda T, Yamamoto S, Matsuda K, Yoshida T, Matsumoto K, Hata K, Kubo M, Matsubara Y, Takahashi H, Fukushima T, Hayashi Y, Koh K, Manabe A, Ohara A; Tokyo Children’s Cancer Study Group (TCCSG).

Haematologica. 2019 Jan;104(1):128-137. doi: 10.3324/haematol.2017.186320. Epub 2018 Aug 31.

8.

Primary diffuse large B-cell lymphoma of the frontal sinus: A case report and literature review.

Nagafuji H, Yokoi H, Ohara A, Fujiwara M, Takayama N, Saito K.

Radiol Case Rep. 2018 Apr 4;13(3):635-639. doi: 10.1016/j.radcr.2018.03.008. eCollection 2018 Jun.

9.

De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome.

Toki T, Yoshida K, Wang R, Nakamura S, Maekawa T, Goi K, Katoh MC, Mizuno S, Sugiyama F, Kanezaki R, Uechi T, Nakajima Y, Sato Y, Okuno Y, Sato-Otsubo A, Shiozawa Y, Kataoka K, Shiraishi Y, Sanada M, Chiba K, Tanaka H, Terui K, Sato T, Kamio T, Sakaguchi H, Ohga S, Kuramitsu M, Hamaguchi I, Ohara A, Kanno H, Miyano S, Kojima S, Ishiguro A, Sugita K, Kenmochi N, Takahashi S, Eto K, Ogawa S, Ito E.

Am J Hum Genet. 2018 Sep 6;103(3):440-447. doi: 10.1016/j.ajhg.2018.07.020. Epub 2018 Aug 23.

PMID:
30146126
10.

Clinical significance of subcutaneous fat and fascial involvement in juvenile dermatomyositis.

Sakurai N, Hino-Shishikura A, Nozawa T, Kamide H, Ohara A, Nishimura K, Kikuchi M, Hara R, Mori M, Ito S.

Mod Rheumatol. 2018 Oct 18:1-6. doi: 10.1080/14397595.2018.1511026. [Epub ahead of print]

PMID:
30092673
11.

Candidate genes responsible for early key events of phenobarbital-promoted mouse hepatocellular tumorigenesis based on differentiation of regulating genes between wild type mice and humanized chimeric mice.

Ohara A, Takahashi Y, Kondo M, Okuda Y, Takeda S, Kushida M, Kobayashi K, Sumida K, Yamada T.

Toxicol Res (Camb). 2017 Aug 24;6(6):795-813. doi: 10.1039/c7tx00163k. eCollection 2017 Nov 1.

12.

Current situation of cancer among adolescents and young adults in Japan.

Ohara A, Furui T, Shimizu C, Ozono S, Yamamoto K, Kawai A, Tatara R, Higuchi A, Horibe K.

Int J Clin Oncol. 2018 Dec;23(6):1201-1211. doi: 10.1007/s10147-018-1323-2. Epub 2018 Jul 30. Erratum in: Int J Clin Oncol. 2018 Oct 15;:.

PMID:
30062493
13.

Specific alteration of gene expression profile in rats by treatment with thyroid toxicants that inhibit thyroid hormone synthesis.

Ohara A, Yamada F, Fukuda T, Suzuki N, Sumida K.

J Appl Toxicol. 2018 Dec;38(12):1529-1537. doi: 10.1002/jat.3693. Epub 2018 Jul 25.

PMID:
30047161
14.

Characterization of a large UNC13D gene duplication in a patient with familial hemophagocytic lymphohistiocytosis type 3.

Hiejima E, Shibata H, Yasumi T, Shimodera S, Hori M, Izawa K, Kawai T, Matsuoka M, Kojima Y, Ohara A, Nishikomori R, Ohara O, Heike T.

Clin Immunol. 2018 Jun;191:63-66. doi: 10.1016/j.clim.2018.03.012. Epub 2018 Mar 26.

PMID:
29596912
15.

Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group (TCCSG) Study L04-16.

Takahashi H, Kajiwara R, Kato M, Hasegawa D, Tomizawa D, Noguchi Y, Koike K, Toyama D, Yabe H, Kajiwara M, Fujimura J, Sotomatsu M, Ota S, Maeda M, Goto H, Kato Y, Mori T, Inukai T, Shimada H, Fukushima K, Ogawa C, Makimoto A, Fukushima T, Ohki K, Koh K, Kiyokawa N, Manabe A, Ohara A.

Int J Hematol. 2018 Jul;108(1):98-108. doi: 10.1007/s12185-018-2440-4. Epub 2018 Mar 27.

PMID:
29589281
16.

Regional evaluation of childhood acute lymphoblastic leukemia genetic susceptibility loci among Japanese.

Urayama KY, Takagi M, Kawaguchi T, Matsuo K, Tanaka Y, Ayukawa Y, Arakawa Y, Hasegawa D, Yuza Y, Kaneko T, Noguchi Y, Taneyama Y, Ota S, Inukai T, Yanagimachi M, Keino D, Koike K, Toyama D, Nakazawa Y, Kurosawa H, Nakamura K, Moriwaki K, Goto H, Sekinaka Y, Morita D, Kato M, Takita J, Tanaka T, Inazawa J, Koh K, Ishida Y, Ohara A, Mizutani S, Matsuda F, Manabe A.

Sci Rep. 2018 Jan 15;8(1):789. doi: 10.1038/s41598-017-19127-7.

17.

Live-attenuated vaccines in a cryopyrin-associated periodic syndrome patient receiving canakinumab treatment during infancy.

Watanabe M, Nishikomori R, Fujimaki Y, Heike T, Ohara A, Saji T.

Clin Case Rep. 2017 Sep 12;5(11):1750-1755. doi: 10.1002/ccr3.1149. eCollection 2017 Nov.

18.

[Disorder of Gastric Myoelectric Activity in Patients with Cerebral Infarction:Electrogastrographic Assessment].

Kinekawa F, Sasaoka N, Matsuda K, Kita Y, Okura R, Nakabayashi R, Ohara A, Nakao K, Inoue T, Tokuda M, Kokudo Y, Masaki T.

No Shinkei Geka. 2017 Jul;45(7):575-582. doi: 10.11477/mf.1436203554. Japanese.

PMID:
28720739
19.

A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.

Chihara Y, Shimoda M, Hori A, Ohara A, Naoi Y, Ikeda JI, Kagara N, Tanei T, Shimomura A, Shimazu K, Kim SJ, Noguchi S.

Breast Cancer Res Treat. 2017 Nov;166(1):55-68. doi: 10.1007/s10549-017-4382-6. Epub 2017 Jul 12.

PMID:
28702892
20.

Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia.

Seki M, Kimura S, Isobe T, Yoshida K, Ueno H, Nakajima-Takagi Y, Wang C, Lin L, Kon A, Suzuki H, Shiozawa Y, Kataoka K, Fujii Y, Shiraishi Y, Chiba K, Tanaka H, Shimamura T, Masuda K, Kawamoto H, Ohki K, Kato M, Arakawa Y, Koh K, Hanada R, Moritake H, Akiyama M, Kobayashi R, Deguchi T, Hashii Y, Imamura T, Sato A, Kiyokawa N, Oka A, Hayashi Y, Takagi M, Manabe A, Ohara A, Horibe K, Sanada M, Iwama A, Mano H, Miyano S, Ogawa S, Takita J.

Nat Genet. 2017 Aug;49(8):1274-1281. doi: 10.1038/ng.3900. Epub 2017 Jul 3.

PMID:
28671687
21.

A Proinflammatory Effect of the β-Glucan from Pleurotus cornucopiae Mushroom on Macrophage Action.

Minato KI, Ohara A, Mizuno M.

Mediators Inflamm. 2017;2017:8402405. doi: 10.1155/2017/8402405. Epub 2017 May 15.

22.

Plasma asparaginase activity, asparagine concentration, and toxicity after administration of Erwinia asparaginase in children and young adults with acute lymphoblastic leukemia: Phase I/II clinical trial in Japan.

Ogawa C, Taguchi F, Goto H, Koh K, Tomizawa D, Ohara A, Manabe A.

Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26475. Epub 2017 Feb 28.

PMID:
28244643
23.

Exome sequencing identified RPS15A as a novel causative gene for Diamond-Blackfan anemia.

Ikeda F, Yoshida K, Toki T, Uechi T, Ishida S, Nakajima Y, Sasahara Y, Okuno Y, Kanezaki R, Terui K, Kamio T, Kobayashi A, Fujita T, Sato-Otsubo A, Shiraishi Y, Tanaka H, Chiba K, Muramatsu H, Kanno H, Ohga S, Ohara A, Kojima S, Kenmochi N, Miyano S, Ogawa S, Ito E.

Haematologica. 2017 Mar;102(3):e93-e96. doi: 10.3324/haematol.2016.153932. Epub 2016 Dec 1. No abstract available.

24.

New possible biomarkers for diagnosis of infections and diagnostic distinction between bacterial and viral infections in children.

Yusa T, Tateda K, Ohara A, Miyazaki S.

J Infect Chemother. 2017 Feb;23(2):96-100. doi: 10.1016/j.jiac.2016.11.002. Epub 2016 Nov 25.

25.

Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy.

Nozawa T, Nishimura K, Ohara A, Hara R, Ito S.

Mod Rheumatol. 2016 Dec 14:1-5. [Epub ahead of print]

PMID:
27846755
26.

Vitrectomy and scleral imbrication in patients with myopic traction maculopathy and macular hole retinal detachment.

Ando Y, Hirakata A, Ohara A, Yokota R, Orihara T, Hirota K, Koto T, Inoue M.

Graefes Arch Clin Exp Ophthalmol. 2017 Apr;255(4):673-680. doi: 10.1007/s00417-016-3523-7. Epub 2016 Nov 10.

27.

Long-term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyte globulin and cyclosporine.

Nishikawa E, Yagasaki H, Hama A, Yabe H, Ohara A, Kosaka Y, Kudo K, Kobayashi R, Ohga S, Morimoto A, Watanabe KI, Yoshida N, Muramatsu H, Takahashi Y, Kojima S.

Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26305. Epub 2016 Nov 3.

PMID:
27808465
28.

Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children.

Kato M, Ishimaru S, Seki M, Yoshida K, Shiraishi Y, Chiba K, Kakiuchi N, Sato Y, Ueno H, Tanaka H, Inukai T, Tomizawa D, Hasegawa D, Osumi T, Arakawa Y, Aoki T, Okuya M, Kaizu K, Kato K, Taneyama Y, Goto H, Taki T, Takagi M, Sanada M, Koh K, Takita J, Miyano S, Ogawa S, Ohara A, Tsuchida M, Manabe A.

Leukemia. 2017 Mar;31(3):580-584. doi: 10.1038/leu.2016.274. Epub 2016 Oct 4.

PMID:
27698447
29.

ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.

Hirabayashi S, Ohki K, Nakabayashi K, Ichikawa H, Momozawa Y, Okamura K, Yaguchi A, Terada K, Saito Y, Yoshimi A, Ogata-Kawata H, Sakamoto H, Kato M, Fujimura J, Hino M, Kinoshita A, Kakuda H, Kurosawa H, Kato K, Kajiwara R, Moriwaki K, Morimoto T, Nakamura K, Noguchi Y, Osumi T, Sakashita K, Takita J, Yuza Y, Matsuda K, Yoshida T, Matsumoto K, Hata K, Kubo M, Matsubara Y, Fukushima T, Koh K, Manabe A, Ohara A, Kiyokawa N; Tokyo Children’s Cancer Study Group (TCCSG).

Haematologica. 2017 Jan;102(1):118-129. doi: 10.3324/haematol.2016.151035. Epub 2016 Sep 15.

30.

Pleurotus citrinopileatus polysaccharide induces activation of human dendritic cells through multiple pathways.

Minato KI, Laan LC, Ohara A, van Die I.

Int Immunopharmacol. 2016 Nov;40:156-163. doi: 10.1016/j.intimp.2016.08.034. Epub 2016 Sep 1.

PMID:
27592080
31.

Erythrocyte glutathione is a novel biomarker of Diamond-Blackfan anemia.

Utsugisawa T, Uchiyama T, Toki T, Ogura H, Aoki T, Hamaguchi I, Ishiguro A, Ohara A, Kojima S, Ohga S, Ito E, Kanno H.

Blood Cells Mol Dis. 2016 Jul;59:31-6. doi: 10.1016/j.bcmd.2016.03.007. Epub 2016 Apr 11.

PMID:
27282564
32.

Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan.

Imamura T, Kiyokawa N, Kato M, Imai C, Okamoto Y, Yano M, Ohki K, Yamashita Y, Kodama Y, Saito A, Mori M, Ishimaru S, Deguchi T, Hashii Y, Shimomura Y, Hori T, Kato K, Goto H, Ogawa C, Koh K, Taki T, Manabe A, Sato A, Kikuta A, Adachi S, Horibe K, Ohara A, Watanabe A, Kawano Y, Ishii E, Shimada H.

Blood Cancer J. 2016 May 13;6:e419. doi: 10.1038/bcj.2016.28.

33.

Formal Total Synthesis of (±)-Strictamine Based on a Gold-Catalyzed Cyclization.

Nishiyama D, Ohara A, Chiba H, Kumagai H, Oishi S, Fujii N, Ohno H.

Org Lett. 2016 Apr 1;18(7):1670-3. doi: 10.1021/acs.orglett.6b00536. Epub 2016 Mar 24.

PMID:
27011119
34.

Detecting central-venous oxygen desaturation without a central-venous catheter: Utility of the difference between invasively and noninvasively measured blood pressure.

Kumasawa J, Ohara A, Kohata H, Aoyagi K, Fukuma S, Fukuhara S.

J Crit Care. 2016 Jun;33:257-61. doi: 10.1016/j.jcrc.2016.02.022. Epub 2016 Mar 2.

PMID:
26994778
35.

Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group.

Keino D, Kinoshita A, Tomizawa D, Takahashi H, Ida K, Kurosawa H, Koike K, Ota S, Iwasaki N, Fujimura J, Yuza Y, Kiyotani C, Yamamoto S, Osumi T, Ueda T, Mochizuki S, Isoyama K, Hanada R, Tawa A, Manabe A, Toguchi Y, Ohara A.

Int J Hematol. 2016 Apr;103(4):416-22. doi: 10.1007/s12185-016-1937-y. Epub 2016 Jan 18.

PMID:
26781613
36.

ALDH2 polymorphism in patients with Diamond-Blackfan anemia in Japan.

Ikeda F, Toki T, Kanezaki R, Terui K, Yoshida K, Kanno H, Ohga S, Ohara A, Kojima S, Ogawa S, Ito E.

Int J Hematol. 2016 Jan;103(1):112-4. doi: 10.1007/s12185-015-1891-0. Epub 2015 Nov 25. No abstract available.

PMID:
26608366
37.

Favorable outcome in non-infant children with MLL-AF4-positive acute lymphoblastic leukemia: a report from the Tokyo Children's Cancer Study Group.

Tomizawa D, Kato M, Takahashi H, Fujimura J, Inukai T, Fukushima T, Kiyokawa N, Koh K, Manabe A, Ohara A.

Int J Hematol. 2015 Nov;102(5):602-10. doi: 10.1007/s12185-015-1869-y. Epub 2015 Sep 26.

PMID:
26410102
38.

Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.

Narita A, Muramatsu H, Sekiya Y, Okuno Y, Sakaguchi H, Nishio N, Yoshida N, Wang X, Xu Y, Kawashima N, Doisaki S, Hama A, Takahashi Y, Kudo K, Moritake H, Kobayashi M, Kobayashi R, Ito E, Yabe H, Ohga S, Ohara A, Kojima S; Japan Childhood Aplastic Anemia Study Group.

Haematologica. 2015 Dec;100(12):1546-52. doi: 10.3324/haematol.2015.132530. Epub 2015 Aug 27.

39.

Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine.

Hama A, Takahashi Y, Muramatsu H, Ito M, Narita A, Kosaka Y, Tsuchida M, Kobayashi R, Ito E, Yabe H, Ohga S, Ohara A, Kojima S.

Haematologica. 2015 Nov;100(11):1426-33. doi: 10.3324/haematol.2015.128553. Epub 2015 Aug 13.

40.

A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia.

Gocho Y, Kiyokawa N, Ichikawa H, Nakabayashi K, Osumi T, Ishibashi T, Ueno H, Terada K, Oboki K, Sakamoto H, Shioda Y, Imai M, Noguchi Y, Arakawa Y, Kojima Y, Toyama D, Hata K, Yoshida T, Matsumoto K, Kato M, Fukushima T, Koh K, Manabe A, Ohara A; Tokyo Children’s Cancer Study Group.

Leukemia. 2015 Dec;29(12):2445-8. doi: 10.1038/leu.2015.111. Epub 2015 May 6. No abstract available.

PMID:
25943178
41.

Methylone-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.

Piao YS, Hall FS, Moriya Y, Ito M, Ohara A, Kikura-Hanajiri R, Goda Y, Lesch KP, Murphy DL, Uhl GR, Sora I.

Behav Pharmacol. 2015 Jun;26(4):345-52. doi: 10.1097/FBP.0000000000000135.

PMID:
25794333
42.

Outcome of pediatric acute lymphoblastic leukemia with very late relapse: a retrospective analysis by the Tokyo Children's Cancer Study Group (TCCSG).

Kato M, Manabe A, Saito AM, Koh K, Inukai T, Ogawa C, Goto H, Tsuchida M, Ohara A.

Int J Hematol. 2015 Jan;101(1):52-7. doi: 10.1007/s12185-014-1710-z. Epub 2014 Nov 29.

PMID:
25432437
43.

Loss of function mutations in RPL27 and RPS27 identified by whole-exome sequencing in Diamond-Blackfan anaemia.

Wang R, Yoshida K, Toki T, Sawada T, Uechi T, Okuno Y, Sato-Otsubo A, Kudo K, Kamimaki I, Kanezaki R, Shiraishi Y, Chiba K, Tanaka H, Terui K, Sato T, Iribe Y, Ohga S, Kuramitsu M, Hamaguchi I, Ohara A, Hara J, Goi K, Matsubara K, Koike K, Ishiguro A, Okamoto Y, Watanabe K, Kanno H, Kojima S, Miyano S, Kenmochi N, Ogawa S, Ito E.

Br J Haematol. 2015 Mar;168(6):854-64. doi: 10.1111/bjh.13229. Epub 2014 Nov 25.

PMID:
25424902
44.

TKI dasatinib monotherapy for a patient with Ph-like ALL bearing ATF7IP/PDGFRB translocation.

Kobayashi K, Miyagawa N, Mitsui K, Matsuoka M, Kojima Y, Takahashi H, Ootsubo K, Nagai J, Ueno H, Ishibashi T, Sultana S, Okada Y, Akimoto S, Okita H, Matsumoto K, Goto H, Kiyokawa N, Ohara A.

Pediatr Blood Cancer. 2015 Jun;62(6):1058-60. doi: 10.1002/pbc.25327. Epub 2014 Nov 14.

PMID:
25400122
45.

First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy.

Yoshida N, Kobayashi R, Yabe H, Kosaka Y, Yagasaki H, Watanabe K, Kudo K, Morimoto A, Ohga S, Muramatsu H, Takahashi Y, Kato K, Suzuki R, Ohara A, Kojima S.

Haematologica. 2014 Dec;99(12):1784-91. doi: 10.3324/haematol.2014.109355. Epub 2014 Sep 5.

46.

[A case of atypical hemolytic uremic syndrome successfully weaned from plasma exchange by treatment with eculizumab].

Nagata A, Ohara A, Wakasugi D, Natori C, Ito S, Taguchi K, Fukami K, Okuda S.

Nihon Jinzo Gakkai Shi. 2014;56(5):606-11. Japanese.

PMID:
25130033
47.

Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children's Cancer Study Group (TCCSG) clinical trials.

Kato M, Manabe A, Koh K, Inukai T, Kiyokawa N, Fukushima T, Goto H, Hasegawa D, Ogawa C, Koike K, Ota S, Noguchi Y, Kikuchi A, Tsuchida M, Ohara A.

Int J Hematol. 2014 Aug;100(2):180-7. doi: 10.1007/s12185-014-1622-y. Epub 2014 Jun 18.

PMID:
24938380
48.

Peripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemia.

Sakaguchi H, Nishio N, Hama A, Kawashima N, Wang X, Narita A, Doisaki S, Xu Y, Muramatsu H, Yoshida N, Takahashi Y, Kudo K, Moritake H, Nakamura K, Kobayashi R, Ito E, Yabe H, Ohga S, Ohara A, Kojima S; Japan Childhood Aplastic Anemia Study Group.

Haematologica. 2014 Aug;99(8):1312-6. doi: 10.3324/haematol.2013.091165. Epub 2014 May 9.

49.

Prognostic impact of gained chromosomes in high-hyperdiploid childhood acute lymphoblastic leukaemia: a collaborative retrospective study of the Tokyo Children's Cancer Study Group and Japan Association of Childhood Leukaemia Study.

Kato M, Imamura T, Manabe A, Hashii Y, Koh K, Sato A, Takahashi H, Hori H, Taki T, Inoue M, Hayashi Y, Horibe K, Tsuchida M, Kojima S, Oda M, Ohara A.

Br J Haematol. 2014 Jul;166(2):295-8. doi: 10.1111/bjh.12836. Epub 2014 Mar 17. No abstract available.

PMID:
24628674
50.

ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children.

Kobayashi K, Mitsui K, Ichikawa H, Nakabayashi K, Matsuoka M, Kojima Y, Takahashi H, Iijima K, Ootsubo K, Oboki K, Okita H, Yasuda K, Sakamoto H, Hata K, Yoshida T, Matsumoto K, Kiyokawa N, Ohara A.

Br J Haematol. 2014 Jun;165(6):836-41. doi: 10.1111/bjh.12834. Epub 2014 Mar 15.

PMID:
24628626

Supplemental Content

Support Center